Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator

A. Friedman, Paul; Murgatroyd, Francis; V.A. Boersma, Lucas; Manlucu, Jaimie; O’Donnell, David; P. Knight, Bradley; Clémenty, Nicolas; Leclercq, Christophe; K. Amin, Anish; Merkely, Béla; Birgersdotter‐Green, Ulrika; Yat‐Sun Chan, Joseph; Biffi, Mauro; E. Knops, Reinoud; Engel, Greg; Muñoz Carvajal, Ignacio; M. Epstein, Laurence; Sagi, Venkata; Brock Johansen, Jens; Sterliński, Maciej; Steinwender, Clemens; Hounshell, Troy; Abben, Richard; Thompson, Amy; Wiggenhorn, Christopher; Willey, Sarah; Crozier, Ian

doi:10.1056/nejmoa2206485

Public

Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator

Published in New England Journal of Medicine • Aug 28, 2022

Authors:

Paul A. Friedman

Francis Murgatroyd

Lucas V.A. Boersma

Abstract

BACKGROUND: The extravascular implantable cardioverter-defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to that of transvenous ICDs. The safety and efficacy of extravascular ICDs are not yet know...

Subject

Implantable cardioverter-defibrillator

Medicine

Cardiology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!